NR3C1 gene polymorphisms are associated with steroid resistance in patients with primary nephrotic syndrome

Pharmacogenomics

Volumn 19, Issue 1, 2018, Pages 45-60

  Liu, Jie ^a,b   Wan, Zan ^a,b   Song, Qianqian ^a,b   Li, Zhi ^a,b   He, Yijing ^a,b   Tang, Yongjun ^a,b   Xie, Wanying ^a,b   Xie, Yanyun ^a   Zhang, Jun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

primary nephrotic syndrome; single nucleotide polymorphisms; steroid resistance

Indexed keywords

CELL NUCLEUS RECEPTOR; NUCLEAR RECEPTOR NR3C1; PREDNISOLONE; PREDNISONE; UNCLASSIFIED DRUG; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; NR3C1 PROTEIN, HUMAN; STEROID;

ADULT; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC RISK; GENETIC VARIATION; HAN CHINESE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; NR3C1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; DRUG RESISTANCE; GENE FREQUENCY; GENETICS;

ADULT; ALLELES; DRUG RESISTANCE; FEMALE; GENE FREQUENCY; GLUCOCORTICOIDS; HAPLOTYPES; HUMANS; MALE; NEPHROTIC SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GLUCOCORTICOID; STEROIDS;

EID: 85038589340     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs-2017-0084     Document Type: Article

References (37)

1. Kidney disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int. Suppl. 2, 139-274 (2012).
2. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 373(9678), 1905-1917 (2009).
3. Cuzzoni E, De Iudicibus S, Franca R et al. Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome. Pharmacogenomics 16(14), 1631-1648 (2015).
4. Swierczewska M, Ostalskanowicka D, Kempisty B, Nowicki M, Zabel M. Molecular basis of mechanisms of steroid resistance in children with nephrotic syndrome. Acta Biochim. Polonica 60(3), 339-344 (2013).
5. Yan H, ZhangDY, Li X et al. Long non-coding RNA GAS5 polymorphism predicts a poor prognosis of acute myeloid leukemia in Chinese patients via affecting hematopoietic reconstitution. Leuk. Lymphoma 58(8), 1948-1957 (2017).
6. Hu C, Xun Q, Li X et al. GLCCI1 variation is associated with asthma susceptibility and inhaled corticosteroid response in a Chinese Han population. Arch. Med. Res. 47(2), 118-125 (2016).
7. Che R, Zhang A. Mechanisms of glucocorticoid resistance in idiopathic nephrotic syndrome. Kidney Blood Press. Res. 37(4-5), 360-378 (2013).
8. Lovric S, Ashraf S, Tan W, Hildebrandt F. Genetic testing in steroid-resistant nephrotic syndrome: when and how? Nephrol. Dial. Transpl. 31(11), 1802-1813 (2015).
9. Boute N, Gribouval O, Roselli S et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat. Genet. 24(4), 349-354 (2000).
10. Honda K, Yamada T, Endo R et al. Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J. Cell. Biol. 140(6), 1383-1393 (1998).
11. Kaplan JM, Kim SH, North KN et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat. Genet. 24(3), 251-256 (2000).
12. Faix J, Grosse R. Staying in shape with formins. Dev. Cell. 10(6), 693-706 (2006).
13. Chhabra ES, Ramabhadran V, Gerber SA, Higgs HN. INF2 is an endoplasmic reticulum-associated formin protein. J. Cell Sci. 122(Pt 9), 1430-1440 (2009).
14. Brown EJ, Schlondorff JS, Becker DJ et al. Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nat. Genet. 42(1), 72-76 (2010).
15. Moore CD, Roberts JK, Orton CR et al. Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes. Drug Metab. Dispos. 41(2), 379-389 (2013).
16. Jonsson G, Astrom A, Andersson P. Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver. Drug Metab. Dispos. 23(1), 137-142 (1995).
17. Seckl JR. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action. Curr. Opin. Pharmacol. 4(6), 597-602 (2004).
18. Callen DF, Baker E, Simmers RN, Seshadri R, Roninson IB. Localization of the human multiple drug resistance gene, MDR1, to 7q21. 1. Hum. Genet. 77(2), 142-144 (1987).
19. Dilger K, Schwab M, Fromm MF. Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein. Inflamm. Bowel Dis. 10(5), 578-583 (2004).
20. Shibata AR, Troster EJ, Wong HR. Glucocorticoid receptor expression in peripheral WBCs of critically ill children. Pediatr. Crit. Care Med. 16(5), e132-e140 (2015).
21. Drolet G, Rivest S. Corticotropin-releasing hormone and its receptors; an evaluation at the transcription level in vivo. Peptides 22(5), 761-767 (2001).
22. Dautzenberg FM, Hauger RL. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci. 23(2), 71-77 (2002).
23. Pratt WB, Toft DO. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 8(3), 306-360 (1997).
24. Grad I, Picard D. The glucocorticoid responses are shaped by molecular chaperones. Mol. Cell Endocrinol. 275(1-2), 2-12 (2007).
25. Chapman MS, Askew DJ, Kuscuoglu U, Miesfeld RL. Transcriptional control of steroid-regulated apoptosis in murine thymoma cells. Mol. Endocrinol. 10(8), 967-978 (1996).
26. Chapman MS, Qu N, Pascoe S et al. Isolation of differentially expressed sequence tags from steroid-responsive cells using mRNA differential display. Mol. Cell Endocrinol. 108(1-2), R1-R7 (1995).
27. Li X, Zhang J, Wu X et al. Polymorphisms of ABAT, SCN2A and ALDH5A1 may affect valproic acid responses in the treatment of epilepsy in Chinese. Pharmacogenomics 17(18), 2007-2014 (2016).
28. SHEsis. http://analysis. bio-x. cn/myanalysis. php
29. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15(2), 97-98 (2005).
30. Bamberger CM, Bamberger AM, de Castro M, Chrousos GP. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 95(6), 2435-2441 (1995).
31. Sousa AR, Lane SJ, Cidlowski JA, Staynov DZ, Lee TH. Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor ?-isoform. J. Allergy Clin. Immun. 105(5), 943-950 (2000).
32. Honda M, Orii F, Ayabe T et al. Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology 118(5), 859-866 (2000).
33. Krupoves A, Mack D, Deslandres C, Seidman E, Amre DK. Variation in the glucocorticoid receptor gene (NR3C1) may be associated with corticosteroid dependency and resistance in children with Crohn's disease. Pharmacogenet. Genom. 21(8), 454-460 (2011).
34. Hagendorf A1, Koper JW, de Jong FH, Brinkmann AO, Lamberts SW, Feelders RA. Variants alpha, beta and P in peripheral blood mononuclear leukocytes in healthy controls and in patients with hyper-and hypocortisolism. J. Clin. Endocrinol. Metab. 90(11), 6237-6243 (2005).
35. Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E. The human glucocorticoid receptor: molecular basis of biologic function. Steroids 75(1), 1-12 (2010).
36. Teeninga N, Holthe JK, Van EL, Kersten MC, Boersma E. Genetic and in vivo determinants of glucocorticoid sensitivity in relation to clinical outcome of childhood nephrotic syndrome. Kidney Int. 85(6), 1444-1453 (2014).
37. van Rossum EFC, Roks PHM, de Jong FH et al. Characterization of a promoter polymorphism in the glucocorticoid receptor gene and its relationship to three other polymorphisms. Clin. Endocrinol. 61(5), 573-581 (2004).